Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Asset disposition
Translate Bio, Inc. (TBIO) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/28/2021 GN Translate Bio to Present at the 7th Annual Truist Securities Life Sciences Summit
04/20/2021 GN Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
04/19/2021 GN Translate Bio Announces Key Leadership Additions and Promotions
04/19/2021 GN Translate Bio Announces Publication of Preclinical Results of COVID-19 mRNA Vaccine Candidate MRT5500 in npj Vaccines
04/07/2021 GN Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
03/23/2021 GN Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
03/22/2021 GN Translate Bio Appoints Dr. Rand Sutherland as President
03/17/2021 GN Translate Bio Announces Results from Second Interim Data Analysis from Ongoing Phase 1/2 Clinical Trial of MRT5005 in Patients with Cystic Fibrosis (CF)
03/12/2021 GN Sanofi and Translate Bio Initiate Phase 1/2 Clinical Trial of mRNA COVID-19 Vaccine Candidate
02/18/2021 GN Translate Bio to Present at the SVB Leerink Virtual 10th Annual Global Healthcare Conference
02/03/2021 GN Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
12/22/2020 GN Translate Bio Announces Departure of Chief Financial Officer
11/12/2020 GN Translate Bio to Participate in Upcoming Investor Conferences
11/05/2020 GN Translate Bio Announces Third Quarter 2020 Financial Results and Reviews Recent Progress
10/15/2020 GN Sanofi and Translate Bio mRNA COVID-19 Vaccine Candidate Induced High Antibody Levels in Preclinical Studies
10/07/2020 GN Translate Bio Highlights mRNA Platform Potential for the Treatment of Cystic Fibrosis (CF) at the 34th Annual North American Cystic Fibrosis Conference
09/29/2020 GN Translate Bio to Participate in Upcoming Investor Conferences
09/03/2020 GN Translate Bio to Participate in Upcoming Investor Conferences
08/06/2020 GN Translate Bio Announces Second Quarter 2020 Financial Results and Reviews Recent Progress
07/20/2020 GN Translate Bio Announces Closing of Expanded Collaboration and Licensing Agreement with Sanofi Pasteur to Develop mRNA Vaccines for All Infectious Diseases
06/25/2020 GN Translate Bio Announces Pricing of Public Offering of Common Stock

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy